Browse All

Current Filters

CLEAR FILTER x

TITLE

Integrated Genomic, Proteomic, and Transcriptomic Profiling Support Cathepsin-B as a Drug Repurposing Target in Cerebral Small Vessel Disease

Author:Rivier, Cyprien   Huo, Shufan   Clocchiatti-Tuozzo, Santiago   Renedo, Daniela   Sharma, Richa   Payabvash, Sam   Rangaraju, Srikant   Dong, Xianjun   Sheth, Kevin   Sansing, Lauren   Falcone, Guido   

Session Name:S2: Advances in Stroke Imaging and Biomarkers  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:S2.001  

Author Institution:Yale University, New Haven, CT  Yale University, Department of Neurology, New Haven, CT  Massachusetts General Hospital, Brigham, Harvard, Boston, MA  Emory University, Atlanta, Atlanta, GA  Yale University, Department of Neurology, Boston, MA  Yale UniversityDivision of Neuro and Critical Care, New Haven, CT  Yale School of Medicine, New Haven, CT  

Novel Bispecific Degrader BHV-1310 Achieves Rapid, Robust, and Selective IgG Reduction in Preclinical Models including Nonhuman Primates

Author:Nicholson, Simone   Dierks, Elizabeth   Kazmierski, Wes   Poole, Chuck   Dubowchik, Gene   Pirman, David   Spiegel, David   Bunin, Anna   Sharpe, Neal   Coric, Vlad   Car, Bruce   

Session Name:S18: Paraneoplastic Neurological Disorders, irAE, Stiff Person, IGLON5  

Topic:Autoimmune Neurology  

Program Number:S18.009  

Author Institution:Biohaven Pharmaceuticals, Inc. , New Haven, CT  Allucent, Cary, NC  Biohaven Pharmaceuticals, Inc. , Cambridge, MA  Yale University, New Haven, CT  

Cognitive Trajectories 1 Year Before and After COVID-19 in an Early-Treated HIV Cohort

Author:Ocampo, Ferron   Hamby, Tyler   Poonpitak, Luxe-naree   Sacdalan, Carlo   Sriplienchan, Somchai   Phanuphak, Nittaya   Chan, Phillip   Crowell, Trevor   Trautmann, Lydie   Vasan, Sandhya   Paul, Robert   Spudich, Serena   

Session Name:S19: Navigating Neuroinfectious Diseases  

Topic:Infectious Disease  

Program Number:S19.005  

Author Institution:University of Toronto, Toronto, ON, Canada  Yale University, New Haven, CT  

Air Pollution and Dopamine in Parkinson’s Disease

Author:Saraiya, Riya   Cayir, Salih   Pala, Vania   Tezel, Melike   Solomon, Beaza   Elshahat, Amr   Matuskey, David   

Session Name:S21: Movement Disorders: Clinical Characteristics and Epidemiology of Movement Disorders  

Topic:Movement Disorders  

Program Number:S21.001  

Author Institution:Yale University, Istanbul, Turkey  Istanbul University, Istanbul, Turkey  Yale University, New Haven, CT  

Polygenic Resistance to Vascular Risk Factor Control in Stroke Survivors

Author:Huo, Shufan   Rivier, Cyprien   Clocchiatti-Tuozzo, Santiago   Renedo, Daniela   Torres-Lopez, Victor   Sunmonu, N. Abimbola   Petersen, Nils   De Havenon, Adam   Sheth, Kevin   Falcone, Guido   

Session Name:S30: Stroke Risk Factors, Outcomes, and Prevention  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:S30.006  

Author Institution:Yale University, New Haven, CT  Yale University, Department of Neurology, New Haven, CT  Yale University, Hamden, CT  Yale Neurology, New Haven, CT  Yale UniversityDivision of Neuro and Critical Care, New Haven, CT  Yale School of Medicine, New Haven, CT